Sui Zhuqi, Chen Baoqiang, Zhao Jia, Yang Haidong, Guo Longhua, Xu Jianguo
Jiaxing Key Laboratory of Molecular Recognition and Sensing, College of Biological and Chemical Engineering, Jiaxing University, Jiaxing 314001, China.
Fujian Key Laboratory of Translational Research in Cancer and Neurodegenerative Diseases, School of Basic Medical Sciences, Fujian Medical University, Fuzhou 350122, China.
Anal Chem. 2025 Aug 12;97(31):17076-17084. doi: 10.1021/acs.analchem.5c02845. Epub 2025 Jul 31.
To meet the growing demand for ultrasensitive diagnostics, representative hybrid platforms integrating nonenzymatic isothermal nucleic acid amplification such as catalytic hairpin assembly (CHA) with CRISPR/Cas systems have been developed. However, two major challenges remain: background leakage from spontaneous hairpin hybridization and inherent fluorescence from conventional ssDNA reporters. Here, we present a self-sustaining isothermal biosensing platform that addresses these limitations by combining CHA with a split activator-initiated CRISPR/Cas12a feedback circuit for the ultrasensitive detection of miRNA-155, a key biomarker of breast cancer. In our design, miRNA-155 initiates CHA to form a DNA duplex, which, along with the miRNA, acts as split activators to trigger CRISPR/Cas12a. Cas12a cleaves a ds-loop DNA reporter, releasing fluorescence and regenerating the target. This dual-recognition mechanism ensures strict target dependence, reduces background noise, and, with the reporter design, minimizes leakage. The released miRNA reactivates CHA, enabling continuous signal amplification through a self-sustaining feedback loop involving successive CHA and Cas12a trans-cleavage cycles, enhancing detection sensitivity. Via these features, the platform achieves attomolar sensitivity and excellent specificity, even distinguishing single-base miRNA variants. Direct detection of endogenous miRNA-155 in serum samples from breast cancer patients demonstrated clear differentiation from healthy controls. This strategy provides a robust molecular detection platform for the accurate and ultrasensitive detection of low-abundance miRNAs in biomedical studies.
为了满足对超灵敏诊断不断增长的需求,已经开发了代表性的混合平台,该平台将非酶等温核酸扩增(如催化发夹组装(CHA))与CRISPR/Cas系统整合在一起。然而,仍然存在两个主要挑战:自发发夹杂交引起的背景泄漏和传统单链DNA报告分子的固有荧光。在这里,我们提出了一种自持等温生物传感平台,该平台通过将CHA与分裂激活剂启动的CRISPR/Cas12a反馈回路相结合,解决了这些限制,用于超灵敏检测乳腺癌的关键生物标志物miRNA-155。在我们的设计中,miRNA-155启动CHA形成DNA双链体,该双链体与miRNA一起作为分裂激活剂触发CRISPR/Cas12a。Cas12a切割双链环DNA报告分子,释放荧光并再生靶标。这种双重识别机制确保了严格的靶标依赖性,降低了背景噪声,并且通过报告分子设计将泄漏降至最低。释放的miRNA重新激活CHA,通过涉及连续CHA和Cas12a反式切割循环的自持反馈回路实现连续信号放大,提高检测灵敏度。通过这些特性,该平台实现了阿托摩尔灵敏度和出色的特异性,甚至能够区分单碱基miRNA变体。对乳腺癌患者血清样本中内源性miRNA-155的直接检测表明,与健康对照有明显区别。该策略为生物医学研究中低丰度miRNA的准确和超灵敏检测提供了一个强大的分子检测平台。